![Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes | npj Digital Medicine Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes | npj Digital Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41746-022-00606-9/MediaObjects/41746_2022_606_Fig1_HTML.png)
Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes | npj Digital Medicine
How to Use the American Diabetes Association's Type 2 Diabetes Treatment Algorithm Disclosures of Interest Key points to empha
Cristobal Morales on Twitter: "https://t.co/BqC68t1Jwu… 19Dec2019 Update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by ADA/EASD @SEDiabetes @sociedadSEEN @redGDPS @SEMERGENap @semfyc @Sociedad_SEMI @secardiologia ...
![JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes](https://www.mdpi.com/jcm/jcm-09-00912/article_deploy/html/images/jcm-09-00912-g001.png)
JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
![New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2018/09/Fig-2-for-EASD-ADA.jpg)
New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia
![Edgar V. Lerma 🇵🇭 on Twitter: "Glucose lowering medications in Type 2 Diabetes: Established ASCVD or CKD #Nephpearls #Cardiorenal #AHA18 🇺🇸 👉🏼 https://t.co/E11n7xQkjL https://t.co/ZqqvqpZeWt" / Twitter Edgar V. Lerma 🇵🇭 on Twitter: "Glucose lowering medications in Type 2 Diabetes: Established ASCVD or CKD #Nephpearls #Cardiorenal #AHA18 🇺🇸 👉🏼 https://t.co/E11n7xQkjL https://t.co/ZqqvqpZeWt" / Twitter](https://pbs.twimg.com/media/DrrCSHUXgAIxaCB.jpg:large)
Edgar V. Lerma 🇵🇭 on Twitter: "Glucose lowering medications in Type 2 Diabetes: Established ASCVD or CKD #Nephpearls #Cardiorenal #AHA18 🇺🇸 👉🏼 https://t.co/E11n7xQkjL https://t.co/ZqqvqpZeWt" / Twitter
![Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA](https://primarycareipa.org/wp-content/uploads/2020/11/pt-chart1.38_1.jpg)
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA
![From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01281-y/MediaObjects/12933_2021_1281_Fig1_HTML.png)
From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text
![From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01281-y/MediaObjects/12933_2021_1281_Fig2_HTML.png)